Skip to main content
. 2016 Oct 4;7(46):74886–74894. doi: 10.18632/oncotarget.12440

Table 3. Results of univariate and multivariate analyses.

variable Overall Survival In-Field Failure-Free Survival
Log-rank Cox model (HR) Log-rank Cox model (HR)
FIGO III-IV 0.959 -- 0.552 --
Tumor > 5 cm 0.010 0.512 0.002 0.078
Pelvic LN 0.151 -- 0.099 0.288
HR-CTV > 25 cc 0.017 0.030 (2.86) 0.002 0.008 (3.73)
Neutrophiliaa 0.004 0.232 0.000 0.002 (4.50)
Leucocytosisa 0.199 0.962 0.003 0.047 (2.54)
Anemia 0.011 0.026 (3.05) 0.065 0.233
Variable Local Failure-Free Survival Distant Failure-Free Survival
Log-rank Cox model (HR) Log-rank Cox model (HR)
FIGO III-IV 0.669 -- 0.433 --
Tumor > 5 cm 0.003 0.383 0.013 0.005 (3.48)
Pelvic LN 0.914 -- 0.047 0.028 (2.42)
HR-CTV > 25 cc 0.003 0.026 (3.1) 0.075 0.505
Neutrophiliaa 0.000 0.018 (3.1) 0.590 --
Leucocytosisa 0.002 0.287 0.564 --
Anemia 0.036 0.177 0.020 0.324

Variables significant with a p value < 0.1 in univariate analysis were used for multivariate model (significant factors in multivariate analysis in bold).

FIGO: International Federation of Gynecology Obstetrics; HR: hazard ratio (given only if p < 0.05); HR CTV: high risk clinical target volume; LN: lymph nodes.

a

Neutrophilia and leucocytosis were not tested in the same model, as neutrophils are subpopulation of leucocytes.